Immunomic Therapeutics, Inc.
Immunomic Therapeutics is a clinical stage biotech company applying proprietary vaccine technology to the $11 billion dollar allergy market.
Immunomic Therapeutics is a clinical stage biotechnology company with exceptional patented science for application to vaccines and vaccine immunotherapy. LAMP-vax™ significantly increases the effectiveness of the immune response while simplifying overall vaccine design and delivery, yielding safer, more cost-effective human and animal therapies. Our LAMP constructs are currently being in the clinic in a Phase I study for our allergy vaccine.